Inhibition of Prostate Cancer Growth by Estramustineand Etoposide: Evidence For Interaction at the Nuclear Matrix
- 1 June 1993
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 149 (6), 1622-1625
- https://doi.org/10.1016/s0022-5347(17)36463-7
Abstract
Metastatic prostate cancer which is refractory to hormone therapy remains an incurable disease for which there is no effective therapy. We have begun to investigate the nuclear matrix, the RNA-protein network of the nucleus that plays an important role in DNA replication and gene expression, as a target for cancer chemotherapy. It was postulated that estramustine phosphate (EMP), an estradiol-nitrogen mustard conjugate that binds to the nuclear matrix, might enhance the cytotoxicity of etoposide (VP-16), a topoisomerase II inhibitor that acts at the level of the nuclear matrix. In a nascent DNA synthesis assay, EMP and etoposide interact to selectively inhibit new DNA synthesis on the nuclear matrix. In vitro, EMP and etoposide appeared to act synergistically to inhibit the growth of the metastatic Dunning rat prostate adenocarcinoma cell line Mat-LyLu as well as the metastatic human prostate adenocarcinoma cell line PC-3. In vivo, EMP and etoposide inhibited prostate adenocarcinoma growth in the Dunning Copenhagen rat model. These data have formed the basis of a Phase I/II clinical trial to examine the effect of EMP and etoposide in patients with stage D hormone-refractory prostate cancer.Keywords
This publication has 21 references indexed in Scilit:
- Association of topoisomerase II with the hepatoma cell nuclear matrix: The role of intermolecular disulfide bond formationExperimental Cell Research, 1991
- The Tissue Matrix: Cell Dynamics and Hormone Action*Endocrine Reviews, 1990
- Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSABiochemistry, 1990
- Hormone-independent, non-alkylating mechanism of cytotoxicity for estramustineUrological Research, 1987
- Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cellsNature, 1986
- THE ROLE OF THE NUCLEAR MATRIX IN THE ORGANIZATION AND FUNCTION OF DNAAnnual Review of Biophysics, 1986
- Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by Roswell Park Memorial InstituteUrology, 1984
- A structural analysis of the role of the nuclear matrix and DNA loops in the organization of the nucleus and chromosomeJournal of Cell Science, 1984
- The association of transcriptionally active genes with the nuclear matrix of the chicken oviductNucleic Acids Research, 1983
- Supercoiled loops and eucaryotic DNA replicationCell, 1980